Page last updated: 2024-11-02

pamidronate and Proteinuria

pamidronate has been researched along with Proteinuria in 5 studies

Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.

Research Excerpts

ExcerptRelevanceReference
"Five patients receiving increased dose or frequency of pamidronate beyond the recommended dose (90 mg/monthly) exhibited nephrotic proteinuria (range 3."7.71Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. ( Desikan, R; Jagannath, S; Li, ZJ; Raza, S; Sabir, T; Stokes, B; Veksler, Y, 2002)
"Pamidronate has been mainly associated with collapsing focal segmental glomerulosclerosis."3.72Podocyte injury associated glomerulopathies induced by pamidronate. ( Abulezz, SR; Barri, YM; Bonsib, SM; Munshi, NC; Sukumalchantra, S; Walker, PD; Wallach, J, 2004)
"Five patients receiving increased dose or frequency of pamidronate beyond the recommended dose (90 mg/monthly) exhibited nephrotic proteinuria (range 3."3.71Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. ( Desikan, R; Jagannath, S; Li, ZJ; Raza, S; Sabir, T; Stokes, B; Veksler, Y, 2002)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desikan, R1
Veksler, Y1
Raza, S1
Stokes, B1
Sabir, T1
Li, ZJ1
Jagannath, S1
Barri, YM1
Munshi, NC1
Sukumalchantra, S1
Abulezz, SR1
Bonsib, SM1
Wallach, J1
Walker, PD1
Nasr, SH1
Preddie, DC1
Markowitz, GS1
Appel, GB1
D'Agati, VD1
Sauter, M1
Jülg, B1
Porubsky, S1
Cohen, C1
Fischereder, M1
Sitter, T1
Schlondorff, D1
Gröne, HJ1
Vega, E1
Gonzalez, D1
Ghiringhelli, G1
Mautalen, C1

Other Studies

5 other studies available for pamidronate and Proteinuria

ArticleYear
Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma.
    British journal of haematology, 2002, Volume: 119, Issue:2

    Topics: Antineoplastic Agents; Bence Jones Protein; Creatinine; Diphosphonates; Drug Administration Schedule

2002
Podocyte injury associated glomerulopathies induced by pamidronate.
    Kidney international, 2004, Volume: 65, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Biopsy; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis

2004
Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.
    Kidney international, 2006, Volume: 69, Issue:3

    Topics: Acute Kidney Injury; Albumins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Creatinin

2006
Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:6

    Topics: Antineoplastic Agents; Biopsy; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosph

2006
Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1987, Volume: 2, Issue:4

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Infusions, I

1987